Welcome to our dedicated page for Amphenol SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amphenol Corporation filings document the company’s operating results, capital structure, governance and material-event disclosures as a global supplier of connectors, interconnect systems, antennas, sensors and specialty cable products. Form 8-K reports cover quarterly and annual financial results, completed acquisition activity, material agreements, debt offerings and board succession matters.
APH proxy materials address director elections, executive compensation, auditor ratification, stockholder voting procedures and beneficial ownership. Registration and current-report filings also disclose Class A common stock, listed senior notes, unsecured note guarantees by Amphenol, subsidiary financing activity, risk factors and other corporate governance and capital-allocation matters.
Michael R. Ivas, Amphenol Corporation's VP & Corporate Controller, reported an option exercise and an immediate sale of the resulting shares on 08/08/2025. He exercised 50,000 stock options at an exercise price of $18.23 and acquired 50,000 Class A shares, then sold 50,000 Class A shares at a weighted average sale price of $110.0164 (executed in multiple trades between $110.00 and $110.08). After these transactions the filing shows 152,412 shares beneficially owned directly by the reporting person and 0 stock options remaining. The filing also lists indirect holdings of 2,995 shares by children and 1,700 shares by spouse. The report documents conversion/exercise activity and a contemporaneous sale, reducing derivative holdings to zero while leaving a material direct ownership stake.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed Rule 144 sale of 113,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $12,462,837.80 and 1,220,921,111 shares outstanding. The filing shows these shares were acquired on 08/11/2025 by exercise of options under a registered plan and payment was made in cash on the same date.
The filing also lists recent sales by the named seller, William Doherty: 113,000 shares sold on 08/08/2025 for $12,304,750.80 and 160,000 shares sold on 05/30/2025 for $14,326,512.00, totaling 273,000 shares and $26,631,262.80 in gross proceeds during the past three months. The notice includes the seller's representation that no undisclosed material adverse information exists.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $5,500,820.00. The filing states the company has 1,220,921,111 shares outstanding and lists the approximate date of sale as 08/08/2025. The shares were reported acquired the same day by exercise of options under a registered plan and paid for in cash. The notice also discloses a prior sale of 40,000 shares on 05/29/2025 for gross proceeds of $3,551,408.00. The filer affirms they do not possess undisclosed material adverse information.
Amphenol Corporation (APH) Form 144 notice reports a proposed sale of 113,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $12,304,750.80 and an approximate sale date of 08/08/2025. The shares were acquired on 08/08/2025 by exercising options under a registered plan and were to be paid in cash. The filing records total shares outstanding of 1,220,921,111 for the issuer. The document also discloses a prior sale of 160,000 shares on 05/30/2025 that generated gross proceeds of $14,326,512.00. The seller affirms no knowledge of undisclosed material adverse information.